Stay updated on Safety Efficacy HMI-203 in MPS II Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy HMI-203 in MPS II Clinical Trial page.

Latest updates to the Safety Efficacy HMI-203 in MPS II Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check50 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of a Phase 1 study for HMI-203 gene therapy for Mucopolysaccharidosis II, while a new revision number has been added.SummaryDifference21%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Safety Efficacy HMI-203 in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy HMI-203 in MPS II Clinical Trial page.